BioStock: Sepsis - common complication in connection with Covid-19 infection

A new study published in The Lancet shows that sepsis was the most common complication in more than half of patients committed to the first Chinese medical centres that took in patients with Covid-19. In theory, this indicates that a future effective treatment against sepsis could potentially be positioned as a supportive treatment in order to decrease mortality as a consequence of viral infections such as Covid-19.

Read the full article at biostock.se:

https://www.biostock.se/en/sepsis-common-complication-in-connection-with-covid-19-infection/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Subscribe

Quick facts

BioStock: Sepsis - common complication in connection with Covid-19 infection
Tweet this

Quotes

Aptahem is currently focusing on sepsis, but there is possibility for potentially expanding the indication. At present, no such decision has been made, but we are not ruling it out
Mikael Lindstam, CEO Aptahem